The Single-Use Bioreactor Market is estimated to be valued at US$ 1337.67 Mn in 2023 and is expected to exhibit a CAGR of 15.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
The Single-Use Bioreactor Market is expanding owing to the increasing adoption of Single-Use Bioreactors. Single-use bioreactors help reduce risks associated with cleaning validation and cross-contamination. They offer advantages like lower capital costs, simple and rapid installation, increased flexibility of operation, and reduced cleaning and sterilization times.
Market Overview:
Single-use bioreactors are disposable and pre-sterilized bags or containers used for growing microorganisms or culturing cells. They offer scalability from laboratory to manufacturing scale. The key advantages of single-use bioreactors include reduced capital costs, increased flexibility, faster product changeovers, and ease of process scale-up.
Market key trends:
Single-use bioreactors are witnessing high demand owing to the trend of increasing outsourcing of bioproduction by biotech and pharmaceutical companies. Several pharma companies are outsourcing biomanufacturing to contract development and manufacturing organizations (CDMOs) to focus on their core competencies like R&D. With outsourcing gaining traction, CDMOs are widely adopting single-use bioreactors to cater to the growing demand from clients and offer flexible manufacturing capacity. In addition, factors like increasing development of personalized medicines, rising prevalence of chronic diseases, and growing demand for vaccinations are propelling the need for biopharmaceuticals production globally, thereby supporting market growth of single-use bioreactors during the forecast period.
Porter’s Analysis
Threat of new entrants: The threat of new entrants in the single-use bioreactor market is moderate. High costs associated with R&D of bioreactors act as a barrier for new players.
Bargaining power of buyers: The bargaining power of buyers is high owing to the presence of several established players providing cost-effective products. Buyers can negotiate for price discounts.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to availability of substitute materials. However, high switching costs bound buyers to current suppliers.
Threat of new substitutes: Threat of substitutes is low as single-use bioreactors do not have close substitutes that can perform similar functions effectively.
Competitive rivalry: The competitive rivalry in the market is high due to presence of global key players.
SWOT Analysis
Strengths: Growing manufacturing of biologics and vaccines boosts demand. Single-use bioreactors enable reduced costs and increased output.
Weaknesses: Limited material thickness affects strength and lifetime of bags. Lack of standardization increases validation costs.
Opportunities: Emerging markets offer scope for expansion. Growing CROs and custom manufacturing present opportunities.
Threats: Stringent regulations delay approvals. Supply chain disruptions affect availability of raw materials.
Key Takeaways
The global Single-Use Bioreactor Market Share is expected to witness high growth, exhibiting CAGR of 15% over the forecast period, due to increasing demand for biologics and monoclonal antibodies. North America dominated the market in 2023 owing to large presence of established players and growing biopharmaceutical industry in the region. Asia Pacific is projected to witness fastest growth over the forecast period with countries like China and India emerging as high potential markets.
Regional analysis: Asia Pacific market is poised to grow at the fastest rate owing to rising pharmaceutical production, favorable government policies, and low manufacturing costs in the region. China dominates the Asia Pacific market while India is projected to witness highest growth.
Key players: Key players operating in the single-use bioreactor market are Sartorius AG, OmniBRx Biotechnologies, Merck KgaA, Solaris Biotechnology Srl, Eppendorf AG, Distek Inc., Celltainer Biotech BV, ABEC Inc., Thermo Fisher Scientific, and Danaher Corporation (Pall Corporation), among others. These players are focussed on new product launches and expansion strategies to gain higher market share.
Read More,
https://www.newsstatix.com/single-use-bioreactor-market-trends-size-and-share-analysis-2/
The Single-Use Bioreactor Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The report also covers detailed competitive landscape including company profiles of key players operating in the global market.
The key players in the single-use bioreactor market includes Applikon Biotechnology, Cellexus, Celltainer Biotech, Cesco Bioengineering, Container Biotech, Danaher, Distek, Eppendorf, GE Healthcare, Parker Hannifin, PBS Biotech, Pierre Guerin, Sartorius Merck Millipore, Stedi, and Thermo Fisher Scientific.
An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.Get more information on "Global Single-Use Bioreactor Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/single-use-bioreactor-market/download-sampleMarket DynamicsGrowing need of manufacturing multi-drug in pharmaceutical industry is likely to propel the demand for single-use bioreactor.
As single use bioreactor provide flexibility over other conventional bioreactor they are highly in demand in preserve and carry mammalian and bacterial cell application, thereby fueling the market growth.This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis.
These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities.
